Table 1.
Gene | Species | Pathway | Phenotype | References |
---|---|---|---|---|
Wnt ligands | ||||
Wnt2 | Mouse | Canonical | Placental vascular failure, inflow tract development (E. Morrisey, unpublished observations) |
[49] |
Wnt5a | Mouse | Noncanonical | Outflow tract septation | [45, 59] |
Wnt7a | Mouse | Canonical | Cerebral vascular development (with Wnt7b) | [14, 66] |
Wnt7b | Mouse | Canonical | Pulmonary vascular smooth muscle development, cerebral vascular development (with Wnt7a) |
[13, 14, 62, 66, 86] |
Wnt9a | Mouse | Unknown | Epicardial development | [46] |
Wnt11 | Mouse, zebra fish, Xenopus |
Noncanonical | Outflow tract development, cardiac myocyte differentiation |
[15, 17, 60, 69, 91] |
Wnt receptors | ||||
Fzd4 | Mouse | Unknown | Retinal vascular development (with norrin) | [70, 88] |
Fzd5 | Mouse | Unknown | Placental vascular development | [21] |
Norrin | Mouse, human | Canonical | Retinal vascular development (with Fzd4) | [88] |
Lrp5 | Mouse, human | Canonical | Retinal vascular development | [24, 70, 86] |
Lrp6 | Mouse | Canonical | Vascular smooth muscle proliferation and survival | [85] |
Signaling components | ||||
Beta-catenin | Mouse, zebra fish | Canonical | SHF progenitor proliferation, cardiac valve development, adult hypertrophic growth |
[2, 10, 12, 20, 29, 37– 39, 50, 51, 76, 79, 84] |
Dvl1 | Mouse | Unknown | Myofibroblast proliferation | [9] |
Dvl2 | Mouse | Unknown | Outflow tract development | [18] |
Gsk3β | Mouse | Canonical | Adult cardiac hypertrophic growth | [10, 72, 73] |
Vangl2 | Mouse | Noncanonical | Outflow tract development | [54] |
Apc | Zebra fish | Canonical | Cardiac valve development | [20] |
SHF second heart field